• Home
  • News

Zoetis Completes Acquisition of Poultry Hatchery Automation Technology Leader KL Products, Inc.

Thursday, August 6, 2015 4:49 pm EDT

Dateline:

DURHAM, N.C.
"We will be well-positioned to deliver tailored solutions that tightly link use of our category leading EmbrexÒ in ovo vaccine delivery systems with broader automation technology across hatchery operations. It exemplifies our commitment to be the preferred animal health partner to the poultry industry."

DURHAM, N.C. – Aug. 6, 2015 - Zoetis Inc. today announced that it has completed the acquisition of KL Products, Inc., a leader in automation systems for the poultry industry headquartered in London, Ontario, Canada. Terms of the transaction were not disclosed.

“The acquisition enables Zoetis to provide the highly integrated global poultry industry with full automation solutions for hatchery operations,” said Steven Clarken, Vice President and General Manager, Global BioDevices at Zoetis.  “We will be well-positioned to deliver tailored solutions that tightly link use of our category leading EmbrexÒ in ovo vaccine delivery systems with broader automation technology across hatchery operations. It exemplifies our commitment to be the preferred animal health partner to the poultry industry.”

About Zoetis

Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2014, the company generated annual revenue of $4.8 billion. With approximately 10,000 employees worldwide at the beginning of 2015, Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in 120 countries. For more information, visit www.zoetis.com.

DISCLOSURE NOTICES

Forward-Looking Statements: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, expectations regarding products, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, including in the sections thereof captioned “Forward-Looking Information and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.govwww.zoetis.com, or on request from Zoetis.

Media Contacts:

Elinore  White
1-973-443-2835
elinore.y.white@zoetis.com

Christina Lood
1-973-822-7249
christina.lood@zoetis.com